// App-Quantinova.ai

: Impact of sarcomatoid features on treatment outcomes in metastatic clear cell renal cell carcinoma treated with first-line immunotherapy combinations.

Researchers

Presenter

  • Kelly N. Fitzgerald

Principal Investigators

  • Cihan Duzgol

  • Andrea Knezevic

  • Natalie Shapnik

  • Ritesh R Kotecha

  • David H Aggen

  • Maria Isabel Carlo

  • Neil J. Shah

  • Martin H Voss

  • Darren R. Feldman

  • Robert J. Motzer

  • Chung-Han Lee

Medical Centers

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Clear cell renal carcinoma

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Ipilimumab

  • Nivolumab

  • L-Tyrosine

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A